LOVE Cannara Biotech Inc.

1.412USD2.020 CAD · TSX+0.75%Mkt Cap: 139.49M USDP/E: 18.36

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operation…

Institutional holders2 on file

Key Statistics

Company
Market Cap139.49M USD
Enterprise Value150.11M USD
Revenue (TTM)82.02M USD
Gross Profit32.93M USD
Net Income (TTM)9.14M USD
Revenue/Share0.86 USD
Last Price1.412 USD
Fiscal Year EndAug 2025
MR QuarterMay 2026
Employees452
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA13765U2002
Valuation
P/E (Trailing)18.36
P/E (Forward)9.93
PEG—
EV/EBITDA8.68
EV/Revenue1.83
P/S1.70
P/B1.59
EPS (TTM)0.08 USD
EPS (Forward)0.14 USD
52W Range
1.08457% of range1.657
52W High1.657 USD
52W Low1.084 USD
Profitability
Gross Margin43.94%
Oper. Margin15.55%
EBITDA Margin21.08%
Profit Margin12.20%
ROE12.79%
ROA7.75%
ROIC12.15%
ROCE16.19%
Growth
Revenue Growth16.40%
Earnings Growth22.60%
Cash Flow & Leverage
Operating CF13.99M USD
CapEx (TTM)4.45M USD
FCF Margin2.72%
FCF Yield1.60%
Net Debt10.62M USD
Net Debt/EBITDA0.61
Net Debt/FCF4.76
Balance Sheet
Debt/Equity0.41
Current Ratio3.00
Quick Ratio1.24
Book Value/Sh0.89 USD
Cash/Share0.15 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)2.359 USD
Upside (mean)+67.1%
Target Range2.097 USD – 2.796 USD
2.097+67.1% to mean2.796
# Analysts4
Ownership
Shares Out.98.78M
Float45.21M
Insiders50.16%
Institutions0.27%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short2.46K
Short (prev mo.)7.86K
Technical
SMA 501.437 (-1.8%)
SMA 2001.313 (+7.5%)
Beta0.32
S&P 52W Chg12.00%
Avg Vol (30d)34.54K
Avg Vol (10d)32.85K
Technical Indicators
RSI (14)48.0
MACD-0.0102
MACD Signal-0.0085
MACD Hist.-0.0017
BB Upper1.463 USD
BB Middle1.415 USD
BB Lower1.368 USD
BB Width6.76%
ATR (14)0.0426 USD
Vol Ratio (20d)0.20x

About Cannara Biotech (TSE: LOVE)

›

Cannara Biotech (TSE: LOVE) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 452 employees.

The shares were at 2.020 CAD on 19 November 2026, up 26.3% over 52 weeks. Its 52-week range is 1.550 CAD to 2.370 CAD: the price is 14.8% below the high and 30.3% above the low.

At a market capitalisation of 199.54M CAD, it trades at 18.4 times trailing earnings and 9.9 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 26% for LOVE.

Cannara Biotech reports return on equity of 12.8%, an operating margin of 15.6% and revenue up 16.4% year over year.

Its debt exceeds its cash by 15.19M CAD, a debt-to-equity ratio of 0.41. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 4 analysts cover the stock; their mean price target of 3.375 CAD is 67.1% above the current price. The next earnings report is expected on 23 November 2026.